Company Performance - Allegheny Technologies (ATI) closed at $55.45, down 1.23% from the previous day, underperforming the S&P 500's loss of 1.11% [1] - Over the past month, ATI shares have decreased by 6.62%, compared to the Basic Materials sector's decline of 8.24% and the S&P 500's increase of 0.4% [1] Earnings Projections - ATI is projected to report earnings of $0.59 per share, reflecting a year-over-year decline of 7.81% [2] - The consensus estimate for revenue is $1.09 billion, indicating a 1.98% increase from the same quarter last year [2] - For the annual period, earnings are anticipated to be $2.27 per share, down 11.33% year-over-year, with revenue expected to reach $4.27 billion, up 2.41% [6] Analyst Ratings - ATI currently holds a Zacks Rank of 4 (Sell), with the Zacks Consensus EPS estimate remaining unchanged over the last 30 days [3] - The Zacks Rank system has shown that 1 stocks have contributed an average annual return of +25% since 1988 [3] Valuation Metrics - ATI has a Forward P/E ratio of 24.7, which is higher than the industry average Forward P/E of 22.36, suggesting that ATI is trading at a premium [4] - The company has a PEG ratio of 1.94, compared to the industry average PEG ratio of 1.49 [9] Industry Context - The Steel - Specialty industry, part of the Basic Materials sector, has a Zacks Industry Rank of 79, placing it in the top 32% of over 250 industries [9][10]

Allegheny Technologies (ATI) closed at $54.23 in the latest trading session, marking a +0.04% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.09%. Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw a decrease of 0.1%.Coming into today, shares of the maker of steel and specialty metals had lost 6.57% in the past month. In that same time, the Basic Materials sector lost 7.73%, while the S&P 500 lost 0.29%.Market participants ...

BOLINGBROOK, Ill., Dec. 17, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (OTCMKTS: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, announced today that it is commencing a tender offer to purchase for cash up to 1,650,000 shares of its Class A common stock (the "Shares") at a purchase price of $2.85 per Share.The number of Shares proposed to be purchased in the tender offer represents approximately 37.4% of the Company's currently outstand ...

BOLINGBROOK, Ill., Dec. 3, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, today announced that it received notification from the New York Stock Exchange ("NYSE") indicating that the Company's Class A common stock will be delisted, and trading of its Class A common stock on the NYSE was suspended, after market close on December 3, 2024. The Company today also announced that it is current ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:ATI Inc. (ATI) is a specialty manufacturing company. The Zacks Consensus Estimate for its current year earnings has been revised 5.2% downward over the last 60 days.Bally's Corporation (BALY) is a casino entertainment company. The Zacks Consensus Estimate for its current year earnings has been revised 85.7% downward over the last 60 days.Coca-Cola FEMSA, S.A.B. de C.V. (KOF) is a franchise bottling company.The Zacks Consensus Estimate ...

Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in animal models after one year Alignment with U.S. Food and Drug Administration on development requirements for ATI-1801 NDA Submission HALIFAX, Nova Scotia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug develo ...

The Achievement Continues the Company's Streak in Earning the Rating Annually Since the Program Debuted in 2019BOLINGBROOK, Ill., Nov. 13, 2024 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "Company") today has again earned the "Exceptional" rating from the Center for Medicare and Medicaid Services' (CMS) Merit-Based Incentive Payment System (MIPS) for quality patient care. ATI received the exceptional rating for the fifth consecutive year, every year since the program's inception for physical therapy ...

Sharpens focus on strategic aerospace and defense markets, streamlines operations DALLAS, Nov. 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced it completed the sale of its precision rolled strip operations in New Bedford, Massachusetts and Remscheid, Germany to Ulbrich Stainless Steels and Special Metals, Inc. (Ulbrich)."With this divestiture, ATI sharpens its focus on providing our aerospace and defense customers with the titanium, nickel, and alloyed products that are rolled, melted and/or finished ...

BOLINGBROOK, Ill., Nov. 4, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, today reported financial results for the third quarter ended September 30, 2024."Our consistent efforts to provide access to quality treatment for our patients underscores our strong operational performance in the third quarter," said Sharon Vitti, Chief Executive Officer of ATI. "We continue to see year-over-year ...

Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for the November 6, 2024 shareholders meeting HALIFAX, Nova Scotia, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that the U.S ...